-
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?2021 Atherosclerosis article Medicine Lipoproteins and Cardiovascular Health Open access cited by 1 patent
Dan Atar, J. Wouter Jukema, Bart Molemans, Pam R. Taub, Shinya Goto, François Mach, +5 more
79citations -
The bispecific anti-FGFR1/KLB agonist antibody BFKB1 attenuates non-alcoholic steatohepatitis and atherosclerosis in Ldlr-/-.Leiden mice2023 Atherosclerosis article Biochemistry, Genetics and Molecular Biology Fibroblast Growth Factor Research Open access cited by 3 patents
José A. Inia, Joanne L. Attema, Corine de Ruiter, Martien P. M. Caspers, Lars Verschuren, J. Wouter Jukema, +2 more
0citations
3 results